GGrantIndex
Sort

64,565 grants matching drug discovery

The Hepato/Renal Fibrocystic Disease Core Center

$1,103,340
Bradley K. Yoder · University Of Alabama At Birmingham · P30 · FY2017 · DK

The Hepato/Renal Fibrocystic Disease Core Center

$1,103,340
Bradley K. Yoder · University Of Alabama At Birmingham · P30 · FY2019 · DK

The Hepato/Renal Fibrocystic Disease Core Center

$1,103,340
Bradley K. Yoder · University Of Alabama At Birmingham · P30 · FY2018 · DK

Novel small-molecule therapies for CF

$1,103,274
University Of California San Francisco · P30 · FY2005 · DK

The role of cancer in cardiovascular disease

$1,102,957
Nicholas James Leeper · Stanford University · R35 · FY2025 · HL

Medical Scientist Training Program

$1,102,950
Terence S. Dermody · Vanderbilt University · T32 · FY2014 · GM

Pathobiology of Neurodegeneration in C9ORF72 Repeat Expansion

$1,102,845
Leonard Petrucelli · Mayo Clinic Jacksonville · P01 · FY2016 · NS

Mapping host-microbe-metabolite interactions in 3D to find diet-derived enhancers of immunity

$1,102,792
Robin Knight · University Of California, San Diego · DP1 · FY2020 · AT

Defining the resistome in P. falciparum: evolution and mechanism

$1,102,586
Elizabeth A Winzeler · University Of California, San Diego · R01 · FY2024 · AI

Center for Cancer Experimental Therapeutics

$1,102,500
Barbara Timmermann · University Of Kansas Lawrence · P30 · FY2010 · RR

Mapping host-microbe-metabolite interactions in 3D to find diet-derived enhancers of immunity

$1,102,500
Robin Knight · University Of California, San Diego · DP1 · FY2019 · AT

NEW TRANSLATION INITIATION INHIBITORS FOR CANCER THERAPY

$1,102,391
Harvard University (Medical School) · U19 · FY2003 · CA

Mayo Clinic Center for Clinical Proteomics

$1,101,893
Akhilesh Pandey · Mayo Clinic Rochester · U01 · FY2023 · CA

Small Molecule Therapeutics for Botullinum Neurotoxin A

$1,101,864
Tobin J Dickerson · Scripps Research Institute, The · U01 · FY2013 · AI

Optimizing Novel Dihydroorotate Dehydrogenase Inhibitors for Treating Malaria

$1,101,631
Ian Cyril Bathurst · Medicines For Malaria Venture · U01 · FY2009 · AI

Nipah & Hendra Virus Nonhuman Primate Model & Therapeutics Development

$1,101,571
Thomas William Geisbert · University Of Texas Med Br Galveston · U01 · FY2012 · AI

Leadership in AD/ADRD Drug Discovery

$1,101,512
Stuart A Lipton · Scripps Research Institute, The · R35 · FY2024 · AG

CNTR OF EXCELLENCE FOR PROSTATE CANCER RESEARCH EDUCATION AND COMM SERVICE

$1,101,485
Shafiq A Khan · Clark Atlanta University · P20 · FY2013 · MD

UWCCC National Cooperative Drug Discovery Group for Can*

$1,101,149
Ben Shen · University Of Wisconsin-Madison · U19 · FY2006 · CA

Peptide Receptor Systems

$1,101,118
Ted B Usdin · National Institute Of Mental Health · ZIA · FY2016 · MH

Natural Products Discovery and Characterization Through Network Collaborations

$1,101,094
Lin Du · Division Of Basic Sciences - Nci · ZIA · FY2021 · CA

Higher Order Structure Analysis of Protein Therapeutics by Covalent Labeling MS

$1,100,964
Eric Graban · Reclaim Pharmaceutical Waste Management · R44 · FY2017 · GM

Transcriptional Control of Autoimmunity in the Central Nervous System

$1,100,625
Howard L Weiner · Brigham And Women'S Hospital · P01 · FY2014 · NS

Oxadiazole Inhibitors of Non-Stop Ribosome Rescue to treat MDR Neisseria gonorrhoeae

$1,100,543
Zachary David Aron · Microbiotix, Inc · R01 · FY2019 · AI

Task A02: Product Development Planning and Evaluation - The Lilly TB Drug Discovery Initiative

$1,100,191
Diana Stevens · Research Triangle Institute · N01 · FY2019 · AI